+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Small Molecule Innovator CDMO Market Size, Share & Trends Analysis Report by Product (Small Molecule API, Small Molecule Drug Product), Stage Type, Customer Type, Therapeutic Area, Region, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 119 Pages
  • November 2023
  • Region: Global
  • Grand View Research
  • ID: 5534063
Description Jump to:
The global small molecule innovator CDMO market size is expected to reach USD 74.9 billion by 2030, expanding at a CAGR of 6.21% from 2024 to 2030, according to the report. There is a growing interest among pharmaceutical companies in outsourcing to support core competencies such as sales, marketing, and others, due to associated cost savings. Furthermore, outsourcing enables companies to further progress core competencies such as drug development and manufacturing activities. Hence, expansions by small molecule CDMOs in recent years promise major support for the market growth in the upcoming years.

Small molecules continue to play an important role in the development of new treatments globally. Specialty medicines are increasingly driving global pharmaceutical manufacturing growth, particularly in developed markets with small molecule application accounting for over half of specialty sales. The application of small molecules are becoming increasingly complex.

The majority of solutions in the regulatory approval pipeline are made up of poorly soluble compounds that would require enabling technology to progress to clinical trials and beyond. As therapy targets and focus areas become more specific, creating target product profiles has become increasingly difficult. Failure to achieve appropriate bioavailability is an additional stumbling block in the development of many new chemical entities. These factors are expected to support the overall market growth.

The geriatric population is expected to witness a surge in the coming years. For instance, the WHO estimates that there will be more than 2 billion people aged 60 and over by 2050. This would create a lot of opportunities for the development of new small-molecule drugs, which is expected to support the market growth in the post-pandemic period.

Small Molecule Innovator CDMO Market Report Highlights

  • The small molecule API segment is anticipated to register the fastest CAGR over the forecast period. This growth can primarily be attributed to the high approval rate of NME small molecules by regulatory agencies
  • The clinical stage segment dominated the market with 55.0% of the revenue share in 2023. CDMOs offer specialized expertise, time-saving, and cost-efficiency during clinical procedures. This is expected to augment the segmental growth over the forecast period
  • Based on customer type, the pharmaceutical companies segment held the largest share of 93.98% in 2023. The growing focus on pharmaceutical companies to focus on core competencies, such as sales and adoption of expansion strategies by CDMOs for manufacturing small molecule drugs, are promoting the segment’s market growth
  • The oncology segment dominated the market with 42.09% of the revenue share in 2023, and it is anticipated to register the fastest CAGR over the forecast period. A significant number of oncology drugs in the regulatory approval pipeline is one of the major factors supporting the segment’s growth

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Product
1.1.2 Stage Type
1.1.3 Customer Type
1.1.4 Therapeutic Area
1.1.5 Regional Scope
1.1.6 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Internal database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.5.1 Approaches Used To Estimate The Market Size
1.5.1.1 Approach 1: Region-Wise Market Estimation Using Bottom-Up Approach
1.5.1.2 Approach 2: Parent Market Analysis
1.5.1.3 Approach 3: Commodity Flow (Company Share Analysis)
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.7 List of Secondary Sources
1.8 List of Abbreviations
1.9 Objectives
1.9.1 Objective - 1
1.9.2 Objective - 2
1.9.3 Objective - 3
1.9.4 Objective - 4
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
Chapter 3 Small Molecule Innovators CDMO Market: Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Increasing Demand for Small Molecule Drug
3.2.1.2 Growing Demand for Small Molecules in the Oncology Segment
3.2.1.3 Increasing Pharmaceutical R&D Investments
3.2.2 Market Restraint Analysis
3.2.2.1 Stringent Government Regulations
3.3.2.2 Compliance Issues with Outsourcing
3.3 Small Molecule Innovators CDMO Market Analysis Tools
3.3.1 Porter’s Five Forces Analysis
3.3.2 PESTEL Analysis
3.4 Impact of COVID-19 and Reformation Strategies
Chapter 4 Small Molecule Innovator CDMO Market: Product Segment Analysis
4.1 Small Molecule Innovators CDMO: Market Share Analysis, 2023 & 2030
4.2 Small Molecule API
4.2.1 Small Molecule API, 2018 - 2030 (USD Million)
4.3 Small Molecule Drug Product
4.3.1 Small Molecule Drug Product Market, 2018 - 2030 (USD Billion)
4.3.2 Oral Solid Dose
4.3.2.1 Oral Solid Dose Market, 2018 - 2030 (USD Billion)
4.3.3 Semi-Solid Dose
4.3.3.1 Semi-Solid Dose Market, 2018 - 2030 (USD Billion)
4.3.4 Liquid Dose
4.3.4.1 Liquid-Solid Dose Market, 2018 - 2030 (USD Billion)
4.3.5 Others
4.3.5.1 Others Market, 2018 - 2030 (USD Billion)
Chapter 5 Small Molecule Innovators CDMO Market: Stage Type Segment Analysis
5.1 Small Molecule Innovators Cdmo: Market Share Analysis, 2023 & 2030
5.2 Preclinical
5.2.1 Preclinical Market, 2018 - 2030 (USD Billion)
5.3 Clinical
5.3.1 Clinical Market, 2018 - 2030 (USD Billion)
5.3.2 Phase I
5.3.2.1 Phase I Market, 2018 - 2030 (USD Billion)
5.3.2.2 Small
5.3.2.2.1 Small Market, 2018 - 2030 (USD Billion)
5.3.2.3 Medium
5.3.2.3.1. Medium Market, 2018 - 2030 (USD Billion)
5.3.2.4 Large
5.3.2.4.1. Large Market, 2018 - 2030 (USD Billion)
5.3.3 Phase II
5.3.3.1 Phase II Market, 2018 - 2030 (USD Billion)
5.3.3.2 Small
5.3.3.2.1. Small Market, 2018 - 2030 (USD Billion)
5.3.3.3 Medium
5.3.3.3.1. Medium Market, 2018 - 2030 (USD Billion)
5.3.3.4 Large
5.3.3.4.1. Large Market, 2018 - 2030 (USD Billion)
5.3.4 Phase III
5.3.4.1 Phase III Market, 2018 - 2030 (USD Billion)
5.3.4.2 Small
5.3.4.2.1 Small Market, 2018 - 2030 (USD Billion)
5.3.4.3 Medium
5.3.4.3.1. Medium Market, 2018 - 2030 (USD Billion)
5.3.4.4 Large
5.3.4.4.1. Large Market, 2018 - 2030 (USD Billion)
5.4 Commercial
5.4.1. Commercial Market, 2018 - 2030 (USD Billion)
Chapter 6 Small Molecule Innovators CDMO Market: Customer Type Segment Analysis
6.1 Small Molecule Innovators CDMO: Market Share Analysis, 2023 & 2030
6.2 Pharmaceutical
6.2.1 Pharmaceutical Market, 2018 - 2030 (USD Million)
6.2.2 Small
6.2.2.1 Small Market, 2018 - 2030 (USD Million)
6.2.3 Medium
6.2.3.1 Medium Market, 2018 - 2030 (USD Million)
6.2.4 Large
6.2.4.1 Large Market, 2018 - 2030 (USD Million)
6.3 Biotechnology
6.3.1 Biotechnology Market, 2018 - 2030 (USD Million)
Chapter 7 Small Molecule Innovators CDMO Market: Therapeutic Area Segment Analysis
7.1 Small Molecule Innovators CDMO: Market Share Analysis, 2023 & 2030
7.2 Cardiovascular Disease
7.2.1 Cardiovascular diseases market, 2018 - 2030 (USD Million)
7.3 Oncology
7.3.1 Oncology market, 2018 - 2030 (USD Million)
7.4 Respiratory Disorders
7.4.1 Respiratory disorders market, 2018 - 2030 (USD Million)
7.5 Neurology
7.5.1 Neurology market, 2018 - 2030 (USD Million)
7.6 Metabolic Disorders
7.6.1 Metabolic disorders market, 2018 - 2030 (USD Million)
7.7 Infectious Diseases
7.7.1 Infectious diseases market, 2018 - 2030 (USD Million)
7.8 Others
7.8.1 Others market, 2018 - 2030 (USD Million)
Chapter 8 Small Molecule Innovators CDMO Market: Regional Analysis
8.1 Small Molecule Innovators CDMO: Market Share Analysis, 2023 & 2030
8.2 North America
8.2.1 North America Small Molecule Innovators CDMO market, 2018 - 2030 (USD Million)
8.2.2 U.S.
8.2.2.1 U.S. Small Molecule Innovators CDMO market, 2018 - 2030 (USD Million)
8.2.3 Canada
8.2.3.1 Canada Small Molecule Innovators CDMO market, 2018 - 2030 (USD Million)
8.3 Europe
8.3.1 Europe Small Molecule Innovators CDMO market, 2018 - 2030 (USD Million)
8.3.2 UK
8.3.2.1 UK Small Molecule Innovators CDMO market, 2018 - 2030 (USD Million)
8.3.3 Germany
8.3.3.1 Germany Small Molecule Innovators CDMO market, 2018 - 2030 (USD Million)
8.3.4 France
8.3.4.1 France Small Molecule Innovators CDMO market, 2018 - 2030 (USD Million)
8.3.5 Italy
8.3.5.1 Italy Small Molecule Innovators CDMO market, 2018 - 2030 (USD Million)
8.3.6 Spain
8.3.6.1 Spain Small Molecule Innovators CDMO market, 2018 - 2030 (USD Million)
8.3.7 Denmark
8.3.7.1 Denmark Small Molecule Innovators CDMO market, 2018 - 2030 (USD Million)
8.3.8 Sweden
8.3.8.1 Sweden Small Molecule Innovators CDMO market, 2018 - 2030 (USD Million)
8.3.9 Norway
8.3.9.1 Norway Small Molecule Innovators CDMO market, 2018 - 2030 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific Small Molecule Innovators CDMO market, 2018 - 2030 (USD Million)
8.4.2 India
8.4.2.1 India Small Molecule Innovators CDMO market, 2018 - 2030 (USD Million)
8.4.3 Japan
8.4.3.1 Japan Small Molecule Innovators CDMO market, 2018 - 2030 (USD Million)
8.4.4 China
8.4.4.1 China Small Molecule Innovators CDMO market, 2018 - 2030 (USD Million)
8.4.5 Australia
8.4.5.1 Australia Small Molecule Innovators CDMO market, 2018 - 2030 (USD Million)
8.4.6 South Korea
8.4.6.1 South Korea Small Molecule Innovators CDMO market, 2018 - 2030 (USD Million)
8.4.7 Thailand
8.4.7.1 Thailand Small Molecule Innovators CDMO market, 2018 - 2030 (USD Million)
8.5 Latin America
8.5.1 Latin America Small Molecule Innovators CDMO market, 2018 - 2030 (USD Million)
8.5.2 Brazil
8.5.2.1 Brazil Small Molecule Innovators CDMO market, 2018 - 2030 (USD Million)
8.5.3 Mexico
8.5.3.1 Mexico Small Molecule Innovators CDMO market, 2018 - 2030 (USD Million)
8.5.4 Argentina
8.5.4.1 Argentina Small Molecule Innovators CDMO market, 2018 - 2030 (USD Million)
8.6 MEA
8.6.1 MEA Small Molecule Innovators CDMO market, 2018 - 2030 (USD Million)
8.6.2 South Africa
8.6.2.1 South Africa Small Molecule Innovators CDMO market, 2018 - 2030 (USD Million)
8.6.3 Saudi Arabia
8.6.3.1 Saudi Arabia Small Molecule Innovators CDMO market, 2018 - 2030 (USD Million)
8.6.4 UAE
8.6.4.1 UAE Small Molecule Innovators CDMO market, 2018 - 2030 (USD Million)
8.6.5 Kuwait
8.6.5.1 Kuwait Small Molecule Innovators CDMO market, 2018 - 2030 (USD Million)
Chapter 9 Competitive Landscape
9.1 Company Profiles
9.1.1 Lonza
9.1.1.1 Company overview
9.1.1.2 Financial performance
9.1.1.3 Service benchmarking
9.1.1.4 Strategic initiatives
9.1.2 Patheon (Thermo Fisher Scientific)
9.1.2.1 Company overview
9.1.2.2 Financial performance
9.1.2.3 Service benchmarking
9.1.2.4 Strategic initiatives
9.1.3 Cambrex Corporation
9.1.3.1 Company overview
9.1.3.2 Service benchmarking
9.1.3.3 Strategic initiatives
9.1.4 Catalent, Inc
9.1.4.1 Company overview
9.1.4.2 Financial performance
9.1.4.3 Service benchmarking
9.1.5 Siegfried Holding AG
9.1.5.1 Company overview
9.1.5.2 Financial performance
9.1.5.3 Service benchmarking
9.1.5.4 Strategic initiatives
9.1.6 Recipharm AB
9.1.6.1 Company overview
9.1.6.2 Financial performance
9.1.6.3 Service benchmarking
9.1.6.4 Strategic initiatives
9.1.7 CordenPharma International
9.1.7.1 Company overview
9.1.7.2 Service benchmarking
9.1.7.3 Strategic initiatives
9.1.8 Boehringer ingelheim
9.1.8.1 Company overview
9.1.8.2 Financial performance
9.1.8.3 Service benchmarking
9.1.8.4 Strategic initiatives
9.1.9 Piramal Pharma Solutions
9.1.9.1 Company overview
9.1.9.2 Financial performance
9.1.9.3 Service benchmarking
9.1.9.4 Strategic initiatives
9.1.10 Labcorp Drug Development
9.1.10.1 Company overview
9.1.10.2 Financial performance
9.1.10.3 Service benchmarking
9.1.10.4 Strategic initiatives
9.2 Company Analysis
9.2.1 Heat Map Analysis of Competitors
List of Tables
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Global Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 4. Global Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 5. Global Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 6. Global Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 7. Global Small Molecule Innovator CDMO Market, by Region, 2018 - 2030 (USD Million)
Table 8. North America Small Molecule Innovator CDMO Market, by Country, 2018 - 2030 (USD Million)
Table 9. North America Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 10. North America Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 11. North America Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 12. North America Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 13. U.S. Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 14. U.S. Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 15. U.S. Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 16. U.S. Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 17. Canada Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 18. Canada Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 19. Canada Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 20. Canada Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 21. Europe Small Molecule Innovator CDMO Market, by Country, 2018 - 2030 (USD Million)
Table 22. Europe Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 23. Europe Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 24. Europe Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 25. Europe Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 26. Germany Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 27. Germany Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 28. Germany Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 29. Germany Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 30. UK Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 31. UK Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 32. UK Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 33. UK Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 34. France Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 35. France Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 36. France Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 37. France Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 38. Italy Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 39. Italy Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 40. Italy Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 41. Italy Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 42. Spain Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 43. Spain Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 44. Spain Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 45. Spain Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 46. Denmark Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 47. Denmark Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 48. Denmark Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 49. Denmark Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 50. Sweden Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 51. Sweden Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 52. Sweden Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 53. Sweden Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 54. Norway Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 55. Norway Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 56. Norway Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 57. Norway Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 58. Asia Pacific Small Molecule Innovator CDMO Market, by Country, 2018 - 2030 (USD Million)
Table 59. Asia Pacific Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 60. Asia Pacific Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 61. Asia Pacific Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 62. Asia Pacific Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 63. China Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 64. China Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 65. China Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 66. China Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 67. Japan Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 68. Japan Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 69. Japan Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 70. Japan Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 71. India Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 72. India Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 73. India Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 74. India Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 75. South Korea Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 76. South Korea Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 77. South Korea Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 78. South Korea Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 79. Australia Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 80. Australia Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 81. Australia Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 82. Australia Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 83. ThailandSmall Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 84. ThailandSmall Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 85. ThailandSmall Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 86. ThailandSmall Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 87. Latin America Small Molecule Innovator CDMO Market, by Country, 2018 - 2030 (USD Million)
Table 88. Latin America Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 89. Latin America Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 90. Latin America Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 91. Latin America Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 92. Brazil Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 93. Brazil Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 94. Brazil Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 95. Brazil Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 96. Mexico Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 97. Mexico Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 98. Mexico Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 99. Mexico Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 100. Argentina Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 101. Argentina Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 102. Argentina Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 103. Argentina Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 104. Middle East & Africa Small Molecule Innovator CDMO Market, by Country, 2018 - 2030 (USD Million)
Table 105. Middle East & Africa Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 106. Middle East & Africa Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 107. Middle East & Africa Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 108. Middle East & Africa Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 109. South Africa Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 110. South Africa Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 111. South Africa Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 112. South Africa Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 113. Saudi Arabia Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 114. Saudi Arabia Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 115. Saudi Arabia Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 116. Saudi Arabia Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 117. UAE Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 118. UAE Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 119. UAE Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 120. UAE Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 121. Kuwait Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 122. Kuwait Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 123. Kuwait Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 124. Kuwait Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market formulation & validation
Fig. 7 Commodity flow analysis
Fig. 8 Small Molecule Innovators CDMO market snapshot (2023) (USD Million)
Fig. 9 Small Molecule Innovator market segmentation
Fig. 10 Parent market outlook
Fig. 11 Penetration & growth prospect mapping
Fig. 12 Market driver relevance analysis (Current & future impact)
Fig. 13 Market restraint relevance analysis (Current & future impact)
Fig. 14 Porter’s five forces analysis
Fig. 15 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 16 Small Molecule Innovator CDMO market Product outlook: Segment dashboard
Fig. 17 Small Molecule Innovators CDMO market: Product movement analysis
Fig. 18 Small Molecule API market 2018 - 2030 (USD Million)
Fig. 19 Small Molecule Drug Product Market, 2018 - 2030 (USD Million)
Fig. 20 Oral solid dose Market, 2018 - 2030 (USD Million)
Fig. 21 Semi-solid Dose Market, 2018 - 2030 (USD Million)
Fig. 22 Semi-Solid Dose Market, 2018 - 2030 (USD Million)
Fig. 23 Antibody-drug conjugate market, 2018 - 2030 (USD Million)
Fig. 24 Small Molecule Innovators CDMO market synthesis outlook: segment dashboard
Fig. 25 Small Molecule Innovators CDMO market: Stage type movement analysis
Fig. 26 Preclinical market, 2018 - 2030 (USD Million)
Fig. 27 Clinical market, 2018 - 2030 (USD Million)
Fig. 28 Phase I market, 2018 - 2030 (USD Million)
Fig. 29 Small market, 2018 - 2030 (USD Million)
Fig. 30 Medium market, 2018 - 2030 (USD Million)
Fig. 31 Large market, 2018 - 2030 (USD Million)
Fig. 32 Phase II market, 2018 - 2030 (USD Million)
Fig. 33 Small market, 2018 - 2030 (USD Million)
Fig. 34 Medium market, 2018 - 2030 (USD Million)
Fig. 35 Large market, 2018 - 2030 (USD Million)
Fig. 36 Phase III market, 2018 - 2030 (USD Million)
Fig. 37 Small market, 2018 - 2030 (USD Million)
Fig. 38 Medium market, 2018 - 2030 (USD Million)
Fig. 39 Large market, 2018 - 2030 (USD Million)
Fig. 40 Commercial market, 2018 - 2030 (USD Million)
Fig. 41 Small Molecule Innovators CDMO market synthesis outlook: segment dashboard
Fig. 42 Small Molecule Innovators CDMO market: Customer type movement analysis
Fig. 43 Pharmaceutical market, 2018- 2030 (USD Million)
Fig. 44 Small market, 2018 - 2030 (USD Million)
Fig. 45 Medium market, 2018 - 2030 (USD Million)
Fig. 46 Large market, 2018 - 2030 (USD Million)
Fig. 47 Biotechnology market, 2018 - 2030 (USD Million)
Fig. 48 Small Molecule Innovators CDMO market synthesis outlook: segment dashboard
Fig. 49 Small Molecule Innovators CDMO market: Therapeutic area movement analysis
Fig. 50 Cardiovascular Disease market, 2018 - 2030 (USD Million)
Fig. 51 Oncology market, 2018 - 2030 (USD Million)
Fig. 52 Respiratory Disorders market, 2018 - 2030 (USD Million)
Fig. 53 Neurology market, 2018 - 2030 (USD Million)
Fig. 54 Metabolic disorders market, 2018 - 2030 (USD Million)
Fig. 55 Infectious diseases market, 2018 - 2030 (USD Million)
Fig. 56 Other’s market, 2018 - 2030 (USD Million)
Fig. 57 Regional market: Key takeaways
Fig. 58 Small Molecule Innovators CDMO market: Regional movement analysis
Fig. 59 North America market, 2018 - 2030 (USD Million)
Fig. 60 U.S. market, 2018 - 2030 (USD Million)
Fig. 61 Canada market, 2018 - 2030 (USD Million)
Fig. 62 Europe market, 2018 - 2030 (USD Million)
Fig. 63 UK market, 2018 - 2030 (USD Million)
Fig. 64 Germany market, 2018 - 2030 (USD Million)
Fig. 65 France market, 2018 - 2030 (USD Million)
Fig. 66 Italy market, 2018 - 2030 (USD Million)
Fig. 67 Spain market, 2018 - 2030 (USD Million)
Fig. 68 Denmark market, 2018 - 2030 (USD Million)
Fig. 69 Sweden market, 2018 - 2030 (USD Million)
Fig. 70 Norway market, 2018 - 2030 (USD Million)
Fig. 72 Asia Pacific market, 2018 - 2030 (USD Million)
Fig. 73 India market, 2018 - 2030 (USD Million)
Fig. 74 Japan market, 2018 - 2030 (USD Million)
Fig. 75 China market, 2018 - 2030 (USD Million)
Fig. 76 Australia market, 2018 - 2030 (USD Million)
Fig. 77 South Korea market, 2018 - 2030 (USD Million)
Fig. 78 Thailand market, 2018 - 2030 (USD Million)
Fig. 79 Latin America market, 2018 - 2030 (USD Million)
Fig. 80 Brazil market, 2018 - 2030 (USD Million)
Fig. 81 Mexico market, 2018 - 2030 (USD Million)
Fig. 82 Argentina market, 2018 - 2030 (USD Million)
Fig. 83 MEA market, 2018 - 2030 (USD Million)
Fig. 84 South Africa market, 2018 - 2030 (USD Million)
Fig. 85 Saudi Arabia market, 2018 - 2030 (USD Million)
Fig. 86 UAE market, 2018 - 2030 (USD Million)
Fig. 87 Kuwait market, 2018 - 2030 (USD Million)
Fig. 88 Heat Map Analysis

Companies Profiled

  • Lonza
  • Patheon (Thermo Fisher Scientific)
  • Cambrex Corporation
  • Catalent, Inc
  • Siegfried Holding AG
  • Recipharm AB
  • CordenPharma International
  • Boehringer ingelheim
  • Piramal Pharma Solutions
  • Labcorp Drug Development

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages119
PublishedNovember 2023
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 48.6 Billion
Forecasted Market Value ( USD ) by 2030 $ 74.9 Billion
Compound Annual Growth Rate6.2%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Small Molecule Innovator API CDMO Market Size, Share & Trends Analysis Report By Stage Type (Preclinical, Clinical, Commercial), By Customer Type, By Therapeutic Area, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Small Molecule Innovator API CDMO Market Size, Share & Trends Analysis Report By Stage Type (Preclinical, Clinical, Commercial), By Customer Type, By Therapeutic Area, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 241 Pages
  • Global
From
Small Molecule Innovator API CDMO Market - Product Image

Small Molecule Innovator API CDMO Market

  • Report
  • 200 Pages
  • Global
From
Small Molecule Innovator CDMO Global Market Report 2024 - Product Image

Small Molecule Innovator CDMO Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Small Molecule Innovator CDMO Market - Forecasts from 2024 to 2029 - Product Image

Small Molecule Innovator CDMO Market - Forecasts from 2024 to 2029

  • Report
  • 152 Pages
  • Global
From
Pharmaceutical CDMO Market Size, Share & Trends Analysis Report by Product (API, Drug Product), Workflow (Clinical, Commercial), Application (Oncology, Infectious Diseases, Neurological Disorders), Region, and Segment Forecasts, 2024-2030 - Product Image

Pharmaceutical CDMO Market Size, Share & Trends Analysis Report by Product (API, Drug Product), Workflow (Clinical, Commercial), Application (Oncology, Infectious Diseases, Neurological Disorders), Region, and Segment Forecasts, 2024-2030

  • Report
  • 342 Pages
  • Global
From

About the Small Molecule CMO Market

The Small Molecule CMO market is a subset of the Pharmaceutical Manufacturing industry, focusing on the production of small molecule drugs. Small molecule drugs are typically composed of organic molecules, and are used to treat a variety of conditions, from cancer to cardiovascular disease. CMOs provide a range of services, from drug development and clinical trials to manufacturing and packaging. They are often used to reduce the cost and time associated with drug development, as well as to increase the efficiency of the manufacturing process. CMOs are typically divided into two categories: contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs). CMOs focus on the production of small molecule drugs, while CDMOs provide a range of services, from drug development to manufacturing and packaging. Companies in the Small Molecule CMO market include Boehringer Ingelheim, Catalent, Lonza, Patheon, and Recipharm. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.